| Term es nes pval sidak fdr geneset_size leading_edge leading_edge_size |
| 7oxoc and 7betahc pathways 0.8994118250350499 2.4309701666526475 0.0150584544111191 0.999885329128766 0.2464741590416526 9 P34913,O15118,Q15125 3 |
| Ciliopathies 0.7984948518233244 2.315471603391866 0.0205871368639869 0.9999960413189402 0.3180002914769906 13 Q10713,O43924 2 |
| Glycosaminoglycan degradation 0.965175953079179 2.312699810702917 0.0207391494441515 0.9999963922316454 0.3180002914769906 6 P54802,P16278,P15586,P06865,P08236 5 |
| Degradation pathway of sphingolipids including diseases 0.9527387907396382 2.267864790163143 0.0233374489638182 0.9999992633990944 0.3488948620090834 6 P06280,P17900,P06865,P16278 4 |
| Cholesterol metabolism with bloch and kandutschrussell pathways 0.6655321418069948 2.2338911583238987 0.0254902354711148 0.9999998031458124 0.371784410042114 22 Q9UBM7,Q14739,Q16850,P35610,Q15392,Q15125 6 |
| Oxysterols derived from cholesterol 0.8844882339741054 2.2120449426555475 0.0269635597459878 0.9999999203465224 0.3729200949408559 8 P34913,Q15125 2 |
| Tryptophan metabolism 0.7470262728602977 2.2073603460785627 0.0272888944109781 0.9999999347835976 0.3729200949408559 14 P35610,P51648,Q15392,P05091 4 |
| Metapathway biotransformation phase i and ii 0.6625646728944917 2.2052160599827544 0.0274389367515011 0.9999999405306308 0.3729200949408559 21 P34913,Q16850,Q7LGA3,P07099,Q86UY6 5 |
| Cholesterol biosynthesis with skeletal dysplasias 0.8888042051759185 2.0823183913248933 0.0373133971147146 0.9999999998669584 0.4958535883244295 7 Q16850,Q15392,Q15125,Q14739 4 |
| Sphingolipid metabolism in senescence 0.7934560513388911 2.0669107569393086 0.038742563945499 0.9999999999452798 0.5033801435572663 10 Q06136,Q96G23,P04062,O15269,P16278,Q13510 6 |
| Sphingolipid pathway 0.8387497755878 2.0332439919227943 0.0420278785639214 0.9999999999929364 0.5235973204421878 8 Q06136,Q96G23,O15269,P04062,Q13510 5 |
| Statin inhibition of cholesterol production 0.9034957282098685 1.9860042205451487 0.0470328552762044 0.999999999999692 0.5607291442573207 5 P35610,P01130,Q8WTV0 3 |
| Joubert syndrome 0.6636139244845293 1.9585188324345535 0.0501691634325838 0.9999999999999571 0.5769453794747139 18 Q10713,O43924 2 |
| Ketogenesis and ketolysis 0.8545176438743494 1.9057395683448983 0.0566840028996384 0.9999999999999992 0.6104222998722114 6 P35610,P23786 2 |
| Oxidation by cytochrome p450 0.8659245640641442 1.8479009053434048 0.0646166795492808 1.0 0.6456391136657366 5 Q16850 1 |
| Proximal tubule transport 0.7552006054040018 1.839378676362757 0.0658595082501838 1.0 0.6456391136657366 9 P08183,P08195 2 |
| Sphingolipid metabolism overview 0.8134148904064876 1.795871357664489 0.0725149786746932 1.0 0.647223242499501 7 Q96G23,O15269,Q13510,Q06136 4 |
| Sphingolipid metabolism integrated pathway 0.8134148904064876 1.795871357664489 0.0725149786746932 1.0 0.647223242499501 7 Q96G23,O15269,Q13510,Q06136 4 |
| Fluoroacetic acid toxicity 0.8459312168867505 1.773709433547446 0.0761112252332487 1.0 0.658695572977156 5 P05091 1 |
| Effect of progerin on genes involved in hutchinsongilford progeria syndrome 0.7383579036870923 1.7677372895198151 0.0771048329571921 1.0 0.658695572977156 9 Q13185,Q14839,P83916 3 |
| Nephrotic syndrome 0.7081025389928055 1.737722532441483 0.0822597164350265 1.0 0.6925543781442914 11 O75844 1 |
| Allograft rejection 0.6716866277765693 1.6156713549706356 0.106165387396556 1.0 0.7649024296763915 12 P08183,P10321,P04439,P01889 4 |
| Fatty acid betaoxidation 0.5864835268887397 1.5995039757379552 0.1097086659220409 1.0 0.77307841402666 19 P35610,O43772,P23786 3 |
| Familial hyperlipidemia type 2 0.9754758418740856 1.5553333230132045 0.1198667049981092 1.0 0.7744459984089905 2 P34913 1 |
| Fluoropyrimidine activity 0.6660634024452725 1.546157080290416 0.122066636154309 1.0 0.7744459984089905 11 Q92820 1 |
| Familial hyperlipidemia type 3 0.966691068814056 1.521662177244612 0.1280937493157208 1.0 0.7744459984089905 2 P01130 1 |
| Kennedy pathway from sphingolipids 0.8244377059220689 1.489143447803082 0.1364495988313154 1.0 0.7807112957770199 4 P35790 1 |
| Alpha 6 beta 4 signaling pathway 0.7353894876687019 1.44948297542544 0.1472027513290812 1.0 0.7860171760368294 6 P62993,P42345,Q16539,P28482 4 |
| Inclusion body myositis 0.8090383217755495 1.4326526288550878 0.15195713347497 1.0 0.7860171760368294 4 P05067 1 |
| Familial partial lipodystrophy fpld 0.7192993457143441 1.427748499842373 0.1533642609488936 1.0 0.7860171760368294 7 O75844 1 |
| Notch signaling 0.8029857765481774 1.4104263626318545 0.158413825662961 1.0 0.7860171760368294 4 Q92542 1 |
| Sterol regulatory elementbinding proteins srebp signaling 0.5173258484152577 1.3938551863296489 0.1633613392411939 1.0 0.7860171760368294 29 Q16850,P01130,O95487,Q8WTV0 4 |
| Influence of laminopathies on wnt signaling 0.6324468038084141 1.3910009553254432 0.1642251370597303 1.0 0.7860171760368294 11 O75844 1 |
| Development of ureteric collection system 0.7398525650938714 1.3736225608707235 0.1695588891450685 1.0 0.7860171760368294 5 O94813 1 |
| Serotonin htr1 group and fos pathway 0.6441315695323956 1.3588292106735511 0.1742007147228466 1.0 0.7971667501808769 9 P08754,P36507,P28482,P61586,Q16539,P04899 6 |
| Tgfbeta signaling pathway 0.5049404053738148 1.3223585761085563 0.1860487758268771 1.0 0.8277443107225645 30 P36507,P05067,P63208,Q9Y5K5,P05556,Q16539,P62993,Q96J02,Q9NPI6 9 |
| Genes controlling nephrogenesis 0.7015172232468276 1.3173966493501483 0.1877057034814322 1.0 0.8277443107225645 6 O94813 1 |
| Overlap between signal transduction pathways contributing to lmna laminopathies 0.5696679931139488 1.3101828348416016 0.1901339911549375 1.0 0.8277443107225645 14 O75844,P55209,P50402,P11802,O60725 5 |
| Endoderm differentiation 0.5046806124548355 1.2991222329822485 0.1939019842395852 1.0 0.8277443107225645 28 P05067,O95071,O14981 3 |
| Onecarbon metabolism and related pathways 0.6097781421937594 1.285640756560276 0.1985684658504571 1.0 0.8277443107225645 11 P35790 1 |
| Vitamin b12 metabolism 0.6439685752241482 1.2364579710244967 0.2162883791027581 1.0 0.8453624228983618 8 P01130,Q8WTV0 2 |
| Mapk cascade 0.6790440741742021 1.2295344638573895 0.2188714844747024 1.0 0.8462872266777082 6 P36507,P62993,Q16539,P28482 4 |
| Nitric oxide metabolism in cystic fibrosis 0.7017030506611666 1.2282440029547093 0.2193553848412119 1.0 0.8462872266777082 5 Q86X55,Q99873,O94760 3 |
| Cannabinoid receptor signaling 0.6897616194018006 1.1827537668914572 0.2369067484869376 1.0 0.8719711173734488 5 Q16539,P10644 2 |
| Selenium micronutrient network 0.5791182924101799 1.1757024861567862 0.2397137848006412 1.0 0.8719711173734488 12 P01130 1 |
| S1p receptor signal transduction 0.6637093380766952 1.169576265005938 0.2421715335525398 1.0 0.8719711173734488 6 P04899,P08754,Q13510 3 |
| 4hydroxytamoxifen dexamethasone and retinoic acids regulation of p27 expression 0.6534653465346565 1.166017165214455 0.2436075054504831 1.0 0.8719711173734488 7 P36507,P06730,P28482,P42345,Q96KB5,Q02750 6 |
| Male infertility 0.5321778122729321 1.1654886049577815 0.2438212700848443 1.0 0.8719711173734488 17 P08183 1 |
| Proteoglycan biosynthesis 0.902798837681309 1.16204013878515 0.2452191609990288 1.0 0.8719711173734488 3 Q96L58 1 |
| Vitamin d metabolism 0.9008651187249892 1.15550236227163 0.2478847658085055 1.0 0.8719711173734488 3 Q9UBM7 1 |
| Mitochondrial long chain fatty acid betaoxidation 0.5573354760715878 1.1514938063555062 0.2495291418549738 1.0 0.8726223791185637 13 O43772,P23786 2 |
| Sarscov2 and covid19 pathway 0.8925976708028573 1.127592016511555 0.2594922598585627 1.0 0.8943286307336175 3 P35610 1 |
| Nanoparticlemediated activation of receptor signaling 0.6412408535259977 1.1173620500886814 0.263839554514552 1.0 0.8943286307336175 7 P36507,P28482,P05556,Q16539,P62993 5 |
| Bile acids synthesis and enterohepatic circulation 0.8892773322938083 1.1164029313305532 0.2642496993319123 1.0 0.8943286307336175 3 P01130 1 |
| Wnt signaling pathway and pluripotency 0.5308153774321542 1.106040451916991 0.2687090109473535 1.0 0.8943286307336175 14 P01130 1 |
| Phase i biotransformations non p450 0.8758313199820529 1.071224374396425 0.2840685544496906 1.0 0.8994318843845043 3 Q15165 1 |
| Common pathways underlying drug addiction 0.6278570541286728 1.0641672083213911 0.2872529591093062 1.0 0.8994318843845043 7 P28482,P36507,Q02750,P62140 4 |
| 3q29 copy number variation syndrome 0.5672782601445274 1.0607999923832991 0.2887808056886702 1.0 0.8994318843845043 10 P55210,P02786 2 |
| Progeriaassociated lipodystrophy 0.5685865856917769 1.0254433404437566 0.3051540470392129 1.0 0.9247468844840676 9 O75844 1 |
| Orexin receptor pathway 0.5124748563198442 1.0095894691849716 0.3126920170340064 1.0 0.9247468844840676 14 P01130,P11166 2 |
| Wnt signaling 0.5245316001023028 0.987088546848366 0.3235992319669265 1.0 0.9348422256822322 13 Q8TAA9 1 |
| Photodynamic therapyinduced nfe2l2 nrf2 survival signaling 0.6790703893277032 0.9574027585097664 0.338364006671209 1.0 0.9416054576676524 4 P07099 1 |
| Urea cycle and associated pathways 0.5331997030174904 0.9558606242433648 0.3391426547360781 1.0 0.9416054576676524 12 Q9Y619 1 |
| Spinal cord injury 0.4738894961555293 0.9379151565639752 0.3482880134604209 1.0 0.9416054576676524 19 Q08722,Q9NQC3,O94813,P62942 4 |
| Folate metabolism 0.4960100791887809 0.9326728191603132 0.3509889229124252 1.0 0.9416054576676524 15 P01130 1 |
| P53 transcriptional gene network 0.6025816289035841 0.9320202606466778 0.3513260548706176 1.0 0.9416054576676524 6 P04066,P11166 2 |
| Fragile x syndrome 0.4561744927156051 0.9249055964124132 0.3550150152957059 1.0 0.9416054576676524 36 Q06787,P05067,P51648,P10644 4 |
| Bladder cancer 0.621086122743414 0.9232871530808304 0.3558575809914539 1.0 0.9416054576676524 5 P36507,P11802,P28482 3 |
| Complement system in neuronal development and plasticity 0.5419330678079348 0.9083983247227624 0.363667810531854 1.0 0.9460561270662384 9 Q5KU26 1 |
| Metabolic pathway of ldl hdl and tg including diseases 0.8232203636074451 0.8971977108088538 0.3696134265281507 1.0 0.9460561270662384 3 P01130 1 |
| Proteasome degradation 0.4608890651626894 0.8901973206200396 0.3733599431231309 1.0 0.9460561270662384 41 P04439,P49721,P10321,P01889,P28072 5 |
| Ectoderm differentiation 0.471407918507191 0.8722165261608734 0.3830902655173611 1.0 0.9534105993038726 18 Q13363,P16278 2 |
| Mesodermal commitment pathway 0.4519860496455989 0.8620410585644512 0.3886649241936026 1.0 0.9601484610786728 20 Q8IWS0,P10644,Q07021,O95071,P42858,O94760 6 |
| Cytosine methylation 0.6475049079721868 0.8449740145093916 0.3981253476995463 1.0 0.963367901101659 4 O75874,P48735 2 |
| Ferroptosis 0.4335180395387639 0.8062104224708471 0.4201215301393666 1.0 0.963367901101659 22 P08195,P02786,P37268 3 |
| Cholesterol biosynthesis pathway 0.5041920941991596 0.7953548510161939 0.4264071151396322 1.0 0.963367901101659 11 Q9UBM7,Q16850,P48449,Q13907,P37268 5 |
| Transsulfuration pathway 0.5591249992811917 0.7944894905552928 0.426910524735685 1.0 0.963367901101659 7 P25325,P48507 2 |
| Type ii diabetes mellitus 0.7635431918008783 0.7650541595177581 0.4442392949112772 1.0 0.970238605375234 2 P42345 1 |
| Sudden infant death syndrome sids susceptibility pathways 0.4227008557966391 0.7426887954328224 0.4576701148837054 1.0 0.971276560551375 25 P42892,P10644 2 |
| 1q211 copy number variation syndrome 0.5433390904288093 0.7340810139905497 0.4628993641423777 1.0 0.971276560551375 7 Q9Y624 1 |
| Target of rapamycin tor signaling 0.5371522265374369 0.7106419854857351 0.4773061185192302 1.0 0.976370298085868 7 Q13907,P62942 2 |
| Kallmann syndrome 0.7638227755400953 0.7088963641541164 0.4783887915370557 1.0 0.976370298085868 3 P36507,P62993 2 |
| Erk pathway in huntingtons disease 0.6055520234906246 0.7000114081824765 0.4839201799748915 1.0 0.977308145407501 4 P55210 1 |
| Apoptosisrelated network due to altered notch3 in ovarian cancer 0.4499728034573961 0.6972360971172828 0.4856550521660736 1.0 0.977308145407501 16 P55210,P05067 2 |
| Network map of sarscov2 signaling pathway 0.4110146934164808 0.6669972647946123 0.504773880546852 1.0 0.977308145407501 24 P14635,Q07021,Q08380 3 |
| Mevalonate arm of cholesterol biosynthesis pathway 0.4916285442856857 0.6111929821964371 0.5410718287962941 1.0 0.9940564114747422 8 P35610 1 |
| Complement system 0.4887534656288671 0.6000726419396225 0.5484578243922325 1.0 0.9957477659184156 8 P04899,Q07021 2 |
| Serotonin receptor 467 and nr3c signaling 0.7206151592823145 0.5803299823524213 0.5616921122323864 1.0 0.9957477659184156 3 P36507,P28482 2 |
| Serotonin receptor 2 and elksrfgata4 signaling 0.7206151592823145 0.5803299823524213 0.5616921122323864 1.0 0.9957477659184156 3 P36507,P28482 2 |
| 15q112 copy number variation syndrome 0.5664439534082417 0.5716338324481036 0.5675700698104167 1.0 0.9957477659184156 4 Q06787 1 |
| Vitamin d receptor pathway 0.4542659756098227 0.561477303912407 0.5744721982059167 1.0 0.9957477659184156 10 P08183,P04080 2 |
| Hostpathogen interaction of human coronaviruses autophagy 0.7132918344928597 0.559446769521898 0.575856849988057 1.0 0.9957477659184156 3 O95352,P42345 2 |
| G1 to s cell cycle control 0.3894835729173062 0.5357762336212029 0.5921132095215311 1.0 0.9957477659184156 22 P14635,P15927,Q14181,Q9Y619 4 |
| Exrna mechanism of action and biogenesis 0.6932650073206512 0.5350000746974111 0.5926498056320357 1.0 0.9957477659184156 2 Q9UPY3 1 |
| Primary focal segmental glomerulosclerosis fsgs 0.4156160230766339 0.5184279406812208 0.6041597244209573 1.0 0.998031809955062 16 Q14108 1 |
| Ebola virus infection in host 0.3942570383883431 0.5042455914174293 0.6140888061120489 1.0 1.0 36 P10321,P04439,O15118,P01889 4 |
| Follicle stimulating hormone fsh signaling pathway 0.475728615617859 0.4880888707079698 0.6254868937910958 1.0 1.0 7 P42345,Q9UKG1,Q16539,P28482 4 |
| Neuroinflammation 0.6843311387479156 0.4799041020943803 0.6312955842515102 1.0 1.0 3 Q16539 1 |
| Cysteine and methionine catabolism 0.4940098689438941 0.4785369514382398 0.6322680807458514 1.0 1.0 5 P25325 1 |
| Oncostatin m signaling pathway 0.4073462354636131 0.4745505009791049 0.6351073945360284 1.0 1.0 15 P55210,P01130 2 |
| Hippomerlin signaling dysregulation 0.3988137456425273 0.4702509860534393 0.6381757109938786 1.0 1.0 18 Q4VCS5,P05556,P10644 3 |
| Disruption of postsynaptic signaling by cnv 0.4641014940715767 0.4486870079671904 0.653657458105835 1.0 1.0 7 Q06787 1 |
| Glutathione metabolism 0.4843585222763573 0.4485366167941857 0.6537659659088044 1.0 1.0 5 P48507 1 |
| Mirna biogenesis 0.6686195532771879 0.4389918693108654 0.6606674277395062 1.0 1.0 3 Q9UPY3,Q9HAV4 2 |
| Insulin signaling in adipocytes diabetic condition 0.5121146299046594 0.4091576045172206 0.6824240046295578 1.0 1.0 4 P62753,P42345 2 |
| Insulin signaling in adipocytes normal condition 0.5121146299046594 0.4091576045172206 0.6824240046295578 1.0 1.0 4 P62753,P42345 2 |
| Pathogenic escherichia coli infection 0.3650326539723723 0.3904930841856106 0.6961719682506535 1.0 1.0 23 Q16625 1 |
| Fgfr3 signaling in chondrocyte proliferation and terminal differentiation 0.4385467851833423 0.3557323208754041 0.7220410377148372 1.0 1.0 6 P36507,Q16539,P28482 3 |
| Purinergic signaling 0.6322802279066402 0.3512734308470742 0.7253832255845123 1.0 1.0 3 P04899 1 |
| Hostpathogen interaction of human coronaviruses apoptosis 0.4491897968221546 0.3461994624665751 0.7291928186633274 1.0 1.0 5 P55210,Q16539 2 |
| Microglia pathogen phagocytosis pathway 0.6105417276720395 0.3125776488239368 0.7546015614460948 1.0 1.0 2 Q8NEB9 1 |
| Arrhythmogenic right ventricular cardiomyopathy 0.386995382857198 0.3074147304776221 0.7585277173875098 1.0 1.0 12 Q14126 1 |
| G protein signaling pathways 0.3851046927620705 0.3002650598480768 0.7639749824699178 1.0 1.0 12 P08754,P10644,Q14344,P04899,O43823 5 |
| Exerciseinduced circadian regulation 0.3650727182145353 0.2798828321979233 0.7795673989749976 1.0 1.0 15 Q13185,Q13907,Q93062 3 |
| Dopamine metabolism 0.5940702781844855 0.2764375478723346 0.7822120208039498 1.0 1.0 2 P17612 1 |
| Hedgehog signaling pathway wp4249 0.446153846153848 0.2469675057968417 0.8049333718600193 1.0 1.0 4 P17612,Q13618,Q9Y496 3 |
| Notch signaling pathway 0.364425895460616 0.2245206424421318 0.822352206533357 1.0 1.0 11 Q96J02,P63208,Q92542 3 |
| Airway smooth muscle cell contraction 0.4346380360441569 0.223475987528971 0.8231650697619068 1.0 1.0 4 P62140 1 |
| Praderwilli and angelman syndrome 0.3801881448354164 0.2037328625389111 0.8385622601582394 1.0 1.0 6 Q05086 1 |
| Hippo signaling regulation pathways 0.3488968342456431 0.1926152272466695 0.8472603186261409 1.0 1.0 13 P04899,P08754,P42345,P10644 4 |
| Integrinmediated cell adhesion 0.3308238945916295 0.1883666497377227 0.850589241355165 1.0 1.0 20 P05556,P04632 2 |
| Epithelial to mesenchymal transition in colorectal cancer 0.3269095433377659 0.1703736934919912 0.8647162592181799 1.0 1.0 20 P36507,Q16625 2 |
| Unfolded protein response 0.3868131868131885 0.1429193595714752 0.8863538688025412 1.0 1.0 4 P05198,Q9Y3I0,Q14790 3 |
| Leukocyteintrinsic hippo pathway functions 0.3498349834983488 0.1372963380441688 0.8907965648447536 1.0 1.0 7 Q96GC9,P51153,P63000,P61586,P27348,Q16539 6 |
| Parkinsons disease pathway 0.3302328809759925 0.1253513676111681 0.9002453873691896 1.0 1.0 9 P55212,P55210 2 |
| Transcription cofactors ski and skil protein partners 0.4937774524158168 0.1229358849709707 0.9021578690464812 1.0 1.0 2 O14744 1 |
| Camkk2 pathway 0.3258131463629106 0.1165737189502746 0.9071978649402892 1.0 1.0 10 Q9Y3D6,P28482,O76024,Q13501,P42345 5 |
| Hepatocyte growth factor receptor signaling 0.3257342607848202 0.1163775712430058 0.907353310153318 1.0 1.0 10 P05556 1 |
| Nanomaterial induced apoptosis 0.3292768799762901 0.1076735665214963 0.9142546384431204 1.0 1.0 8 O95831 1 |
| Calcium regulation in cardiac cells 0.3072100001436889 0.1050402340579112 0.916343883130562 1.0 1.0 21 P62942 1 |
| Factors and pathways affecting insulinlike growth factor igf1akt signaling 0.325662429428655 0.0938854942463591 0.9252001168510356 1.0 1.0 7 P05556 1 |
| Nicotine effect on dopaminergic neurons 0.4419626510435739 0.0844015096376421 0.9327372070536148 1.0 1.0 3 P17612,P62136 2 |
| Type i collagen synthesis in the context of osteogenesis imperfecta 0.3168549824522141 0.08207522637995 0.9345868931296272 1.0 1.0 12 Q32P28 1 |
| Nrp1triggered signaling pathways in pancreatic cancer 0.3078576206100697 0.0749843562924689 0.940227158718278 1.0 1.0 10 P36507 1 |
| Pathways affected in adenoid cystic carcinoma 0.3095824967141495 0.0699212985332422 0.9442563008380098 1.0 1.0 13 P36507,Q13363 2 |
| Steroid biosynthesis 0.3590775988286939 0.0615148270142469 0.9509492065188772 1.0 1.0 2 Q99829 1 |
| Hippoyap signaling pathway 0.3491947291361633 0.0605018490360987 0.9517559432317686 1.0 1.0 2 P27348 1 |
| Dual hijack model of vif in hiv infection 0.3771512266569023 0.0598425916600986 0.9522810031021458 1.0 1.0 3 Q15370,Q15369 2 |
| Hypertrophy model 0.3367496339677802 0.0595255075678729 0.9525335493935358 1.0 1.0 2 P06730 1 |
| Striated muscle contraction pathway 0.3016477602280354 0.0593808177502242 0.9526487913133872 1.0 1.0 7 P09493 1 |
| Tgfbeta signaling in thyroid cells for epithelialmesenchymal transition 0.2818448023425984 0.0576568969618947 0.9540219277875444 1.0 1.0 2 P28482 1 |
| Amyotrophic lateral sclerosis als 0.2994395128733026 0.0576307619614317 0.95404274588486 1.0 1.0 10 P36507,O96008,Q16539 3 |
| Mecp2 and associated rett syndrome 0.3069051134293142 0.0545390877158794 0.9565056674223626 1.0 1.0 16 Q05086,Q00013 2 |
| 16p112 distal deletion syndrome 0.2632943490493394 0.0501302836160012 0.9600185672339 1.0 1.0 5 P62993 1 |
| Extracellular vesiclemediated signaling in recipient cells 0.2567765567765592 0.049059517751335 0.960871864690952 1.0 1.0 4 P25054,P35222,P42345 3 |
| Caloric restriction and aging 0.2443913782179274 0.0467177613656257 0.9627381742786822 1.0 1.0 4 P42345 1 |
| Netrinunc5b signaling pathway 0.3010866852074525 0.0445175365957334 0.9644918736520908 1.0 1.0 12 P36507,P28482,P61586,Q16539,Q02750 5 |
| Interleukin1 il1 structural pathway 0.2875846203982596 0.0387017478128384 0.9691281799018144 1.0 1.0 9 P36507,P06730,P28482,Q16539,Q15424 5 |
| Endoplasmic reticulum stress response in coronavirus infection 0.2779935271107921 0.0264659609717031 0.9788856832929204 1.0 1.0 8 P62140 1 |
| Osteoblast differentiation and related diseases 0.2045454545454551 0.0139669905721444 0.9888563161751958 1.0 1.0 6 P78527,P28482,Q8NEB9,Q16539,P35222 5 |
|
|
